Valuation

BMYBristol-Myers Squibb

StockNYSEVereinigte StaatenHealth careEU retail: available

+4,6 % today · +41,4 % over a year

10/10 A 1–10 summary of how an instrument compares with similar ones (same sector and region) by published rules. It describes today's data; it is not a price forecast. More in the glossary → «Balanced» — higher than 95% of the instruments we score

Stability: among the best of its peers; priced lower than most peers. Dividend yield 4,25 %.

Ratios vs sector

Medians of Health care companies in the same region (stocks and REITs).

Lower P/E, P/B, P/S and EV/EBIT mean cheaper; higher yields, returns and margins mean more for the price. Negative multiples (losses) are left out of the medians.
MetricBMYSector medianvs median
P/E13,028,8 · n=11455 % below
P/B5,43,0 · n=19780 % above
P/S2,53,8 · n=20334 % below
EV/EBIT—24,1 · n=103—
Free-cash-flow yield9,4 %2,7 % · n=188245 % above
Dividend yield4,25 %0,00 % · n=216—
Return on equity46,7 %2,4 % · n=1941.842 % above
Return on invested capital—3,4 % · n=177—
Gross margin70,2 %62,5 % · n=15212 % above
Net debt / EBITDA—1,19 · n=108—

Value factor: 84 of 100 within the peer group. Full score breakdown →

Sector peers

The largest companies of the same sector and region.

InstrumentP/EP/BEV/EBITFree-cash-flow yieldDividend yieldSmart Score
LLYEli Lilly & Co42,633,6—1,6 %0,6 %6/10
JNJJohnson & Johnson29,17,2—3,6 %2,1 %8/10
ABBVAbbVie79,9—33,53,6 %3,0 %5/10
MRKMerck114,68,7—4,4 %2,3 %8/10
UNHUnitedHealth25,13,418,66,7 %2,3 %9/10
TMOThermo Fisher Scientific35,74,735,22,9 %0,3 %8/10
AMGNAmgen26,319,724,04,4 %2,3 %6/10
GILDGILEAD—16,1—6,8 %2,1 %4/10
ABTAbbott28,53,426,84,1 %3,0 %5/10
PFEPfizer38,42,0—6,6 %5,9 %1/10

Fiscal-year history

From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.

Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 30 Juni 2026 · filed 30 Juli 2026